DNMT1 and cancer: Although DNMT1 and DMNT3B are also important in cancer development, we did not test the effects of miR-143 on DMNT1 and DMNT3B, because our in silico predictions did not highlight DNMT1 or DMNT3B as the potential binding target of miR-143.